Type II hypersensitivity is characterized by which type of immune response?

Type II hypersensitivity is characterized by which type of immune response?

• A. Immune complex
• B. Antibody-mediated
• C. Delayed-type
• D. Cell-mediated

Answer: (B)

Type II hypersensitivity is primarily characterized by an antibody-mediated immune response. In this type of hypersensitivity reaction, antibodies (specifically IgG or IgM) bind to antigens present on the surface of cells or tissues. This binding can lead to various pathological consequences, including the activation of complement pathways, antibody-dependent cellular cytotoxicity (ADCC), or phagocytosis of the affected cells. In conditions such as autoimmune hemolytic anemia and certain blood transfusion reactions, this mechanism underlies the destruction of the target cells, which are recognized by the immune system as foreign due to the presence of these antibodies. Therefore, the essential feature of Type II hypersensitivity is this direct interaction between antibodies and specific antigens, leading to cellular damage or dysfunction. In contrast, the other types of immune responses listed do not align with the characteristics of Type II hypersensitivity. Immune complex reactions, which involve the accumulation of antigen-antibody complexes, are associated with Type III hypersensitivity. Delayed-type hypersensitivity involves T-cell mediated responses rather than antibodies and is characteristic of Type IV hypersensitivity. Cell-mediated immunity primarily involves T lymphocytes and does not primarily act through antibodies or direct interaction with antigens, which differentiates it from Type II

Type II hypersensitivity is primarily characterized by an antibody-mediated immune response. In this type of hypersensitivity reaction, antibodies (specifically IgG or IgM) bind to antigens present on the surface of cells or tissues. This binding can lead to various pathological consequences, including the activation of complement pathways, antibody-dependent cellular cytotoxicity (ADCC), or phagocytosis of the affected cells.

In conditions such as autoimmune hemolytic anemia and certain blood transfusion reactions, this mechanism underlies the destruction of the target cells, which are recognized by the immune system as foreign due to the presence of these antibodies. Therefore, the essential feature of Type II hypersensitivity is this direct interaction between antibodies and specific antigens, leading to cellular damage or dysfunction.

In contrast, the other types of immune responses listed do not align with the characteristics of Type II hypersensitivity. Immune complex reactions, which involve the accumulation of antigen-antibody complexes, are associated with Type III hypersensitivity. Delayed-type hypersensitivity involves T-cell mediated responses rather than antibodies and is characteristic of Type IV hypersensitivity. Cell-mediated immunity primarily involves T lymphocytes and does not primarily act through antibodies or direct interaction with antigens, which differentiates it from Type II